Abstract:
There is provided amicrobial cell which is capable of producing acetoacetate, 3-hydroxybutyrate and/or 3-hydroxybutyrate variants, wherein the cell is genetically modified to comprise an increased expression relative to its wild type cell of: - an enzyme E 1 capable of catalysing the conversion of acetyl-CoA to acetoacetyl-CoA; - an enzyme E 2 capable of catalysing the conversion of acetoacetyl-CoA to acetoacetate; and -an enzyme E 3 capable of catalysing the conversion of acetoacetate to 3-hydroxybutyrate and/or variants thereof.
Abstract:
A combination of an electrochemical device for delivering reducing equivalents to a cell, and engineered metabolic pathways within the cell capable of utilizing the electrochemically provided reducing equivalents is disclosed. Such a combination allows the production of commodity chemicals by fermentation to proceed with increased carbon efficiency.
Abstract:
Provided are method of synthesizing (R)-5-diphosphomevalonate (DPM), isopentenyl 5-pyrophosphase (IPP), dimethylallyl 5 -pyrophosphate (DMAPP) and isoprenoid using a one-pot synthesis.
Abstract:
The present invention includes methods for increasing white blood cell counts through administration of inhibitors of acyl -coenzyme A : cholesterol acyltransferase 1 (ACAT1). ACAT inhibitors are used to treat symptoms of immunosuppression, either alone or in combination with other treatments.
Abstract:
Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods for modulating or altering metabolism in a cell using isolated and/or purified polypeptides and nucleic acid sequences from Alicyclobacillus acidocaldarius.
Abstract:
Compounds, compositions and methods are provided for modulating the expression of acetyl-CoA acetyltransferase 2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding acetyl-CoA acetyltransferase 2. Methods of using these compounds for modulation of acetyl-CoA acetyltransferase 2 expression and for diagnosis and treatment of disease associated with expression of acetyl-CoA acetyltransferase 2 are provided.
Abstract:
Compounds, compositions and methods are provided for modulating the expression of acetyl-CoA acetyltransferase 2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding acetyl-CoA acetyltransferase 2. Methods of using these compounds for modulation of acetyl-CoA acetyltransferase 2 expression and for diagnosis and treatment of disease associated with expression of acetyl-CoA acetyltransferase 2 are provided.
Abstract:
The present invention relates to a genetically modified microorganism for the fermentative conversion of levulinic acid into propionyl-CoA and acetyl-CoA, and to a fermentation process for performing said conversion.
Abstract:
提供一种羟酰辅酶A脱氢酶基因和一种酰基辅酶A硫解酶基因,及其基因工程菌和应用。所述羟酰辅酶A脱氢酶基因编码如下蛋白质(ⅰ)或(ⅱ):(ⅰ)具有SEQ ID NO:2所示的氨基酸序列;(ⅱ)在(ⅰ)限定的氨基酸序列中经过取代,缺失或者叠加一个或几个氨基酸衍生的蛋白质且与(ⅰ)的蛋白质具有相同的功能。构建缺失羟酰辅酶A脱氢酶基因或酰基辅酶A硫解酶基因的分枝杆菌基因工程菌,并将其用于制备1,4-BNA、4-BNA、9-OH-BNA等甾体化合物。
Abstract:
Provided herein are Lactobacillusmutants having a disruption to an endogenous gene encoding an acetate kinase, wherein the mutants produce increased amounts of recombinant isopropanol. Also described aremethods forproducing the mutants and methods of using the mutants to produce isopropanol.